Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer-Reference-Cited by-同舟云学术

Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer

Published:2022-07-20 Issue:10 Volume:29 Page:1195-1203
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Murakami Yasukiyo¹^ORCID,Matsumoto Kazumasa¹,Miyake Makito²^ORCID,Amano Noriyuki¹,Shimura Soichiro¹,Nishimura Nobutaka²,Iida Kota²^ORCID,Matsushita Yuto³,Abe Takashige⁴^ORCID,Yamada Takeshi⁵,Uemura Motohide⁶,Matsui Yoshiyuki⁷,Taoka Rikiya⁸,Kojima Takahiro⁹,Kobayashi Takashi¹⁰^ORCID,Nishiyama Naotaka¹¹,Kitamura Hiroshi¹¹,Nishiyama Hiroyuki¹²,Fujimoto Kiyohide²^ORCID,Iwamura Masatsugu¹

Affiliation:

1. Department of Urology Kitasato University School of Medicine Kanagawa Japan

2. Department of Urology Nara Medical University Kashihara Nara Japan

3. Department of Urology Hamamatsu University School of Medicine Hamamatsu Japan

4. Department of Urology Hokkaido University Graduate School of Medicine Sapporo Japan

5. Department of Urology Kyoto Prefectural University of Medicine Kyoto Japan

6. Department of Urology Osaka University Graduate School of Medicine Osaka Japan

7. Department of Urology National Cancer Center Hospital Tokyo Japan

8. Department of Urology, Faculty of Medicine Kagawa University Takamatsu Kagawa Japan

9. Department of Urology Aichi Cancer Center Hospital Nagoya Japan

10. Department of Urology Kyoto University Graduate School of Medicine Kyoto Japan

11. Department of Urology, Faculty of Medicine University of Toyama Toyama Japan

12. Department of Urology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14976

Reference30 articles.

1. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2. BACILLUS CALMETTE-GUERIN VERSUS CHEMOTHERAPY FOR THE INTRAVESICAL TREATMENT OF PATIENTS WITH CARCINOMA IN SITU OF THE BLADDER: A META-ANALYSIS OF THE PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALS

3. The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome

4. Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer

5. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment;Journal of Urology;2024-04

2. Controversies in terminology associated with management of BCG‐unresponsive NMIBC in Asia‐Pacific;International Journal of Urology;2023-10-05

3. Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions;Frontiers in Surgery;2023-04-12

4. Editorial Comment from Dr Leow et al. to Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guerin failure in non‐muscle invasive bladder cancer;International Journal of Urology;2022-09-12

5. Editorial Comment from Dr Naselli and Dr Pirola to Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer;International Journal of Urology;2022-07-20